Prevalence of myalgic encephalomyelitis and chronic fatigue syndrome: Difference between revisions
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(→Notable studies: adding remaining authors) |
m (→Notable studies: formatting) |
||
| Line 34: | Line 34: | ||
*2015, Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Redefining an Illness<ref name=":4">{{Cite web|url=http://iom.nationalacademies.org/~/media/Files/Report%20Files/2015/MECFS/MECFScliniciansguide.pdf|title=Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Redefining an Illness|last=|first=|date=2015|website=nationacademies.org|archive-url=|archive-date=|dead-url=|access-date=}}</ref> ([http://iom.nationalacademies.org/~/media/Files/Report%20Files/2015/MECFS/MECFScliniciansguide.pdf Full Text]) | *2015, Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Redefining an Illness<ref name=":4">{{Cite web|url=http://iom.nationalacademies.org/~/media/Files/Report%20Files/2015/MECFS/MECFScliniciansguide.pdf|title=Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Redefining an Illness|last=|first=|date=2015|website=nationacademies.org|archive-url=|archive-date=|dead-url=|access-date=}}</ref> ([http://iom.nationalacademies.org/~/media/Files/Report%20Files/2015/MECFS/MECFScliniciansguide.pdf Full Text]) | ||
*2018, Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe-the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review.<ref>{{Cite journal|last=Murovska|first=Modra|last2=Lacerda|first2=Eliana|last3=Sekulic|first3=Slobodan|last4=Capelli|first4=Enrica|last5=Lorusso|first5=Lorenzo|last6=Shikova|first6=Evelina|last7=Scheibenbogen|first7=Carmen|last8=Alegre|first8=Jose|last9=Pheby|first9=Derek|date=2018-09-01|title=Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review|url=https://bmjopen.bmj.com/content/8/9/e020817|journal=BMJ Open|language=en|volume=8|issue=9|pages=e020817|doi=10.1136/bmjopen-2017-020817|issn=2044-6055|pmid=30181183}}</ref> ([https://bmjopen.bmj.com/content/8/9/e020817.full Full text]) | *2018, Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe-the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review.<ref>{{Cite journal|last=Murovska|first=Modra|last2=Lacerda|first2=Eliana|last3=Sekulic|first3=Slobodan|last4=Capelli|first4=Enrica|last5=Lorusso|first5=Lorenzo|last6=Shikova|first6=Evelina|last7=Scheibenbogen|first7=Carmen|last8=Alegre|first8=Jose|last9=Pheby|first9=Derek|date=2018-09-01|title=Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review|url=https://bmjopen.bmj.com/content/8/9/e020817|journal=BMJ Open|language=en|volume=8|issue=9|pages=e020817|doi=10.1136/bmjopen-2017-020817|issn=2044-6055|pmid=30181183}}</ref> ([https://bmjopen.bmj.com/content/8/9/e020817.full Full text]) | ||
*2018, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning<ref name=":0">{{Cite journal|last=Valdez|first=Ashley R.|author-link=Ashley Valdez|last2=Hancock|first2=Elizabeth E.|author-link2=Elizabeth Hancock|last3=Adebayo|first3=Seyi|author-link3=Seyi Adebayo|last4=Kiernicki|first4=David J.|author-link4=David Kiernicki|last5=Proskauer|first5=Daniel|author-link5=Daniel Proskauer|last6=Attewell|first6=John R.|author-link6=John Attewell|last7=Bateman|first7=Lucinda|author-link7=Lucinda Bateman|last8=DeMaria|first8=Alfred|author-link8=Alfred DeMaria|last9=Lapp|first9=Charles W.|author-link9=Charles Lapp|last10=Rowe|Peter C.|author-link10=Peter Rowe|last11=Proskauer|first11=Charmian|author-link11=Charmaine Proskauer|date=2019-01-08|title=Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning|url=https://www.frontiersin.org/article/10.3389/fped.2018.00412/full|journal=Frontiers in Pediatrics|volume=6|issue=|pages=|doi=10.3389/fped.2018.00412|issn=2296-2360|quote=|via=}}</ref> ([https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331450/ Full text]) | *2018, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning<ref name=":0">{{Cite journal|last=Valdez|first=Ashley R.|author-link=Ashley Valdez|last2=Hancock|first2=Elizabeth E.|author-link2=Elizabeth Hancock|last3=Adebayo|first3=Seyi|author-link3=Seyi Adebayo|last4=Kiernicki|first4=David J.|author-link4=David Kiernicki|last5=Proskauer|first5=Daniel|author-link5=Daniel Proskauer|last6=Attewell|first6=John R.|author-link6=John Attewell|last7=Bateman|first7=Lucinda|author-link7=Lucinda Bateman|last8=DeMaria|first8=Alfred|author-link8=Alfred DeMaria|last9=Lapp|first9=Charles W.|author-link9=Charles Lapp|last10=Rowe|first10=Peter C.|author-link10=Peter Rowe|last11=Proskauer|first11=Charmian|author-link11=Charmaine Proskauer|date=2019-01-08|title=Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning|url=https://www.frontiersin.org/article/10.3389/fped.2018.00412/full|journal=Frontiers in Pediatrics|volume=6|issue=|pages=|doi=10.3389/fped.2018.00412|issn=2296-2360|quote=|via=}}</ref> ([https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6331450/ Full text]) | ||
== See also == | == See also == | ||
Revision as of 16:49, July 10, 2019
The prevalence of myalgic encephalomyelitis and chronic fatigue syndrome is estimated at 17-24 million worldwide.[1] In 2015, the Institute of Medicine (IOM) Report from the United States National Academy of Sciences estimated there were between 836,000 and 2.5 million ME/CFS patients in the U.S.[2] A 2018 study based on insurance claims gave "a rough estimate for the number of patients who may be diagnosed with ME or CFS in the U.S." as between 1.7 million and 3.38 million.[3] Via a machine learning model, the same study predicted the prevalence of ME in the U.S. as roughly 2.8 million (857 out of every 100,000 people).[3]
The IOM Report estimated that between 84% and 91% of patients are not diagnosed.[4][5]
Prevalence of ME/CFS[edit | edit source]
| Country | Prevalence | Population % | Comments |
|---|---|---|---|
| Worldwide | 17,000,000 | ||
| Australia | 100,000 | ||
| Canada | 561,000 | 1.9% | |
| Germany | 300,000 | 0.37% | |
| Japan | 300,000 | ||
| New Zealand | 20,000 | 0.45% | |
| Nigeria | 0.68% | ||
| United Kingdom | 250,000 | 0.4% | |
| United States | 1,000,000 | 0.3% |
Notable studies[edit | edit source]
- 2011, CFS Prevalence and Risk Factors Over Time[6] (Full Text)
- 2015, Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Redefining an Illness[7] (Full Text)
- 2018, Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe-the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review.[8] (Full text)
- 2018, Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning[3] (Full text)
See also[edit | edit source]
References[edit | edit source]
- ↑ "How Many People Have ME/CFS? – American ME and CFS Society". Retrieved January 31, 2019.
- ↑ "Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Redefining and Illness - Report Brief" (PDF). nataionalacademies.org. 2015. Cite has empty unknown parameter:
|dead-url=(help) - ↑ 3.0 3.1 3.2 Valdez, Ashley R.; Hancock, Elizabeth E.; Adebayo, Seyi; Kiernicki, David J.; Proskauer, Daniel; Attewell, John R.; Bateman, Lucinda; DeMaria, Alfred; Lapp, Charles W.; Rowe, Peter C.; Proskauer, Charmian (January 8, 2019). "Estimating Prevalence, Demographics, and Costs of ME/CFS Using Large Scale Medical Claims Data and Machine Learning". Frontiers in Pediatrics. 6. doi:10.3389/fped.2018.00412. ISSN 2296-2360.
- ↑ "What is ME/CFS? | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) | CDC". www.cdc.gov. January 18, 2019. Retrieved January 31, 2019.
- ↑ "Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Key Facts" (PDF). nationalacademies.org. National Academies of Medicine. 2015. Cite has empty unknown parameter:
|dead-url=(help) - ↑ Jason, L. A., Porter, N., Hunnell, J., Rademaker, A., & Richman, J. A. (2011). CFS Prevalence and Risk Factors Over Time. Journal of Health Psychology, 16(3), 445–456. http://doi.org/10.1177/1359105310383603
- ↑ "Beyond Myalgic Encephalomyelitis/Chronic Fatigue Syndrome - Redefining an Illness" (PDF). nationacademies.org. 2015. Cite has empty unknown parameter:
|dead-url=(help) - ↑ Murovska, Modra; Lacerda, Eliana; Sekulic, Slobodan; Capelli, Enrica; Lorusso, Lorenzo; Shikova, Evelina; Scheibenbogen, Carmen; Alegre, Jose; Pheby, Derek (September 1, 2018). "Prevalence and incidence of myalgic encephalomyelitis/chronic fatigue syndrome in Europe—the Euro-epiME study from the European network EUROMENE: a protocol for a systematic review". BMJ Open. 8 (9): e020817. doi:10.1136/bmjopen-2017-020817. ISSN 2044-6055. PMID 30181183.
